ID   ZDH17_MOUSE             Reviewed;         632 AA.
AC   Q80TN5; Q8BJ08; Q8BYQ2; Q8BYQ6;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   07-APR-2021, entry version 149.
DE   RecName: Full=Palmitoyltransferase ZDHHC17 {ECO:0000305};
DE            EC=2.3.1.225 {ECO:0000269|PubMed:15489887, ECO:0000269|PubMed:15603741, ECO:0000269|PubMed:25253725};
DE   AltName: Full=Acyltransferase ZDHHC17 {ECO:0000305|PubMed:28167757};
DE            EC=2.3.1.- {ECO:0000305|PubMed:28167757};
DE   AltName: Full=DHHC domain-containing cysteine-rich protein 17 {ECO:0000305|PubMed:15603741};
DE            Short=DHHC-17 {ECO:0000303|PubMed:15603741};
DE   AltName: Full=Huntingtin-interacting protein 14 {ECO:0000303|PubMed:15489887};
DE   AltName: Full=Zinc finger DHHC domain-containing protein 17 {ECO:0000312|MGI:MGI:2445110};
GN   Name=Zdhhc17 {ECO:0000312|MGI:MGI:2445110};
GN   Synonyms=Hip14 {ECO:0000303|PubMed:12393793},
GN   Kiaa0946 {ECO:0000312|EMBL:BAC65688.1};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=12693553; DOI=10.1093/dnares/10.1.35;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S.,
RA   Nakajima D., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: II.
RT   The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:35-48(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-632 (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Cerebellum, and Hypothalamus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-418 (ISOFORMS 1/2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=12393793; DOI=10.1093/hmg/11.23.2815;
RA   Singaraja R.R., Hadano S., Metzler M., Givan S., Wellington C.L., Warby S.,
RA   Yanai A., Gutekunst C.-A., Leavitt B.R., Yi H., Fichter K., Gan L.,
RA   McGutcheon K., Chopra V., Michel J., Hersch S.M., Ikeda J.E., Hayden M.R.;
RT   "HIP14, a novel ankyrin domain-containing protein, links huntingtin to
RT   intracellular trafficking and endocytosis.";
RL   Hum. Mol. Genet. 11:2815-2828(2002).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=15603741; DOI=10.1016/j.neuron.2004.12.005;
RA   Fukata M., Fukata Y., Adesnik H., Nicoll R.A., Bredt D.S.;
RT   "Identification of PSD-95 palmitoylating enzymes.";
RL   Neuron 44:987-996(2004).
RN   [6]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=15489887; DOI=10.1038/sj.onc.1208171;
RA   Ducker C.E., Stettler E.M., French K.J., Upson J.J., Smith C.D.;
RT   "Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl
RT   acyltransferase.";
RL   Oncogene 23:9230-9237(2004).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18596047; DOI=10.1074/jbc.m802140200;
RA   Greaves J., Salaun C., Fukata Y., Fukata M., Chamberlain L.H.;
RT   "Palmitoylation and membrane interactions of the neuroprotective chaperone
RT   cysteine-string protein.";
RL   J. Biol. Chem. 283:25014-25026(2008).
RN   [8]
RP   INDUCTION.
RX   PubMed=18794299; DOI=10.1074/jbc.m801469200;
RA   Goytain A., Hines R.M., Quamme G.A.;
RT   "Huntingtin-interacting proteins, HIP14 and HIP14L, mediate dual functions,
RT   palmitoyl acyltransferase and Mg2+ transport.";
RL   J. Biol. Chem. 283:33365-33374(2008).
RN   [9]
RP   INTERACTION WITH SPRED1 AND SPRED3.
RX   PubMed=24705354; DOI=10.1093/hmg/ddu137;
RA   Butland S.L., Sanders S.S., Schmidt M.E., Riechers S.P., Lin D.T.,
RA   Martin D.D., Vaid K., Graham R.K., Singaraja R.R., Wanker E.E.,
RA   Conibear E., Hayden M.R.;
RT   "The palmitoyl acyltransferase HIP14 shares a high proportion of
RT   interactors with huntingtin: implications for a role in the pathogenesis of
RT   Huntington's disease.";
RL   Hum. Mol. Genet. 23:4142-4160(2014).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH DNAJC5 AND SNAP25,
RP   MUTAGENESIS OF HIS-465 AND CYS-467, REGION, AND SUBCELLULAR LOCATION.
RX   PubMed=25253725; DOI=10.1091/mbc.e14-06-1169;
RA   Lemonidis K., Gorleku O.A., Sanchez-Perez M.C., Grefen C.,
RA   Chamberlain L.H.;
RT   "The Golgi S-acylation machinery comprises zDHHC enzymes with major
RT   differences in substrate affinity and S-acylation activity.";
RL   Mol. Biol. Cell 25:3870-3883(2014).
RN   [11]
RP   INTERACTION WITH CLIP3; DNAJC5; HTT; MAP6; SNAP23 AND SNAP25.
RX   PubMed=26198635; DOI=10.1074/jbc.m115.657668;
RA   Lemonidis K., Sanchez-Perez M.C., Chamberlain L.H.;
RT   "Identification of a novel sequence motif recognized by the ankyrin repeat
RT   domain of zDHHC17/13 S-acyltransferases.";
RL   J. Biol. Chem. 290:21939-21950(2015).
RN   [12]
RP   FUNCTION, INTERACTION WITH NTRK1, AND DEVELOPMENTAL STAGE.
RX   PubMed=26232532; DOI=10.1016/j.mcn.2015.07.005;
RA   Shi W., Wang F., Gao M., Yang Y., Du Z., Wang C., Yao Y., He K., Chen X.,
RA   Hao A.;
RT   "ZDHHC17 promotes axon outgrowth by regulating TrkA-tubulin complex
RT   formation.";
RL   Mol. Cell. Neurosci. 68:194-202(2015).
RN   [13]
RP   INTERACTION WITH SPRED2.
RX   PubMed=28882895; DOI=10.1074/jbc.m117.799650;
RA   Lemonidis K., MacLeod R., Baillie G.S., Chamberlain L.H.;
RT   "Peptide array based screening reveals a large number of proteins
RT   interacting with the ankyrin repeat domain of the zDHHC17 S-
RT   acyltransferase.";
RL   J. Biol. Chem. 292:17190-17202(2017).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBSTRATE SPECIFICITY.
RX   PubMed=28167757; DOI=10.1073/pnas.1612254114;
RA   Greaves J., Munro K.R., Davidson S.C., Riviere M., Wojno J., Smith T.K.,
RA   Tomkinson N.C., Chamberlain L.H.;
RT   "Molecular basis of fatty acid selectivity in the zDHHC family of S-
RT   acyltransferases revealed by click chemistry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E1365-E1374(2017).
CC   -!- FUNCTION: Palmitoyltransferase that catalyzes the addition of palmitate
CC       onto various protein substrates and is involved in a variety of
CC       cellular processes (PubMed:15489887, PubMed:15603741, PubMed:25253725).
CC       Has no stringent fatty acid selectivity and in addition to palmitate
CC       can also transfer onto target proteins myristate from tetradecanoyl-CoA
CC       and stearate from octadecanoyl-CoA (Probable). Palmitoyltransferase
CC       specific for a subset of neuronal proteins, including SNAP25,
CC       DLG4/PSD95, GAD2, SYT1 and HTT (PubMed:15489887, PubMed:15603741,
CC       PubMed:25253725). Also palmitoylates neuronal protein GPM6A as well as
CC       SPRED1 and SPRED3 (By similarity). Could also play a role in
CC       axonogenesis through the regulation of NTRK1 and the downstream
CC       ERK1/ERK2 signaling cascade (PubMed:26232532). May be involved in the
CC       sorting or targeting of critical proteins involved in the initiating
CC       events of endocytosis at the plasma membrane (By similarity). May play
CC       a role in Mg(2+) transport (By similarity). Could also palmitoylate
CC       DNAJC5 and regulate its localization to the Golgi membrane
CC       (PubMed:18596047). {ECO:0000250|UniProtKB:Q8IUH5,
CC       ECO:0000269|PubMed:18596047, ECO:0000269|PubMed:26232532,
CC       ECO:0000305|PubMed:28167757}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoyl-CoA + L-cysteinyl-[protein] = CoA + S-
CC         hexadecanoyl-L-cysteinyl-[protein]; Xref=Rhea:RHEA:36683, Rhea:RHEA-
CC         COMP:10131, Rhea:RHEA-COMP:11032, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:74151;
CC         EC=2.3.1.225; Evidence={ECO:0000269|PubMed:15489887,
CC         ECO:0000269|PubMed:15603741, ECO:0000269|PubMed:25253725};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36684;
CC         Evidence={ECO:0000305|PubMed:15489887, ECO:0000305|PubMed:15603741,
CC         ECO:0000305|PubMed:25253725};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-cysteinyl-[protein] + tetradecanoyl-CoA = CoA + S-
CC         tetradecanoyl-L-cysteinyl-[protein]; Xref=Rhea:RHEA:59736, Rhea:RHEA-
CC         COMP:10131, Rhea:RHEA-COMP:15433, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57385, ChEBI:CHEBI:143199;
CC         Evidence={ECO:0000305|PubMed:28167757};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59737;
CC         Evidence={ECO:0000305|PubMed:28167757};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-cysteinyl-[protein] + octadecanoyl-CoA = CoA + S-
CC         octadecanoyl-L-cysteinyl-[protein]; Xref=Rhea:RHEA:59740, Rhea:RHEA-
CC         COMP:10131, Rhea:RHEA-COMP:15434, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57394, ChEBI:CHEBI:143200;
CC         Evidence={ECO:0000305|PubMed:28167757};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59741;
CC         Evidence={ECO:0000305|PubMed:28167757};
CC   -!- SUBUNIT: Interacts (via ANK repeats) with numerous proteins (via the
CC       consensus sequence motif [VIAP]-[VIT]-x-x-Q-P) (By similarity).
CC       Interacts (via ANK repeats) with CLIP3 (PubMed:26198635). Interacts
CC       (via ANK repeats) with HTT (PubMed:26198635). Interacts (via ANK
CC       repeats) with DNAJC5 (via C-terminus) (PubMed:25253725,
CC       PubMed:26198635). Interacts (via ANK repeats) with MAP6
CC       (PubMed:26198635). Interacts (via ANK repeats) with SNAP23
CC       (PubMed:26198635). Interacts (via ANK repeats) with SNAP25
CC       (PubMed:25253725, PubMed:26198635). Interacts (via ANK repeats) with
CC       EVL (By similarity). Interacts with SPRED1 and SPRED3
CC       (PubMed:24705354). Interacts with GPM6A and OPTN (By similarity). May
CC       interact (via ANK repeats) with SPRED2 (PubMed:28882895). May interact
CC       with NTRK1; may regulate its localization and function
CC       (PubMed:26232532). {ECO:0000250|UniProtKB:Q8IUH5,
CC       ECO:0000269|PubMed:24705354, ECO:0000269|PubMed:25253725,
CC       ECO:0000269|PubMed:26198635, ECO:0000269|PubMed:26232532,
CC       ECO:0000269|PubMed:28882895}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:18596047, ECO:0000269|PubMed:25253725}; Multi-pass
CC       membrane protein {ECO:0000255}. Cytoplasmic vesicle membrane
CC       {ECO:0000250|UniProtKB:Q8IUH5}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell junction, synapse, presynaptic cell membrane
CC       {ECO:0000250|UniProtKB:Q8IUH5}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Low extracellular Mg(2+) induces increase in Golgi
CC       and in post-Golgi membrane vesicles. {ECO:0000250|UniProtKB:Q8IUH5}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q80TN5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q80TN5-2; Sequence=VSP_010026, VSP_010027;
CC   -!- TISSUE SPECIFICITY: Expressed in liver, testis, kidney, heart, pancreas
CC       and brain. Highest expression was seen in the brain. Localized
CC       predominantly in the perinuclear regions of neurons from the cortex,
CC       striatum and hippocampus. Colocalized with HTT in the medium spiny
CC       neurons of the striatum and the spiny neurons that project into the
CC       globus pallidus. {ECO:0000269|PubMed:12393793}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in neurons during their
CC       differentiation. {ECO:0000269|PubMed:26232532}.
CC   -!- INDUCTION: Up-regulated by low extracellular Mg(2+).
CC       {ECO:0000269|PubMed:18794299}.
CC   -!- DOMAIN: The DHHC domain is required for palmitoyltransferase activity.
CC       {ECO:0000250|UniProtKB:Q8IUH5}.
CC   -!- PTM: Autopalmitoylated. Autopalmitoylation has a regulatory role in
CC       ZDHHC17-mediated Mg(2+) transport. {ECO:0000250|UniProtKB:Q8IUH5}.
CC   -!- SIMILARITY: Belongs to the DHHC palmitoyltransferase family.
CC       AKR/ZDHHC17 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH58772.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAC30090.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC30097.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC32912.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC65688.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK122406; BAC65688.1; ALT_INIT; mRNA.
DR   EMBL; AK038670; BAC30090.2; ALT_INIT; mRNA.
DR   EMBL; AK038681; BAC30097.2; ALT_INIT; mRNA.
DR   EMBL; AK046891; BAC32912.1; ALT_INIT; mRNA.
DR   EMBL; BC058772; AAH58772.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS56748.1; -. [Q80TN5-1]
DR   RefSeq; NP_766142.2; NM_172554.2. [Q80TN5-1]
DR   SMR; Q80TN5; -.
DR   STRING; 10090.ENSMUSP00000043279; -.
DR   iPTMnet; Q80TN5; -.
DR   PhosphoSitePlus; Q80TN5; -.
DR   SwissPalm; Q80TN5; -.
DR   PaxDb; Q80TN5; -.
DR   PeptideAtlas; Q80TN5; -.
DR   PRIDE; Q80TN5; -.
DR   ProteomicsDB; 275138; -. [Q80TN5-1]
DR   ProteomicsDB; 275139; -. [Q80TN5-2]
DR   Antibodypedia; 8807; 195 antibodies.
DR   Ensembl; ENSMUST00000041723; ENSMUSP00000043279; ENSMUSG00000035798. [Q80TN5-1]
DR   GeneID; 320150; -.
DR   KEGG; mmu:320150; -.
DR   UCSC; uc007gzw.2; mouse. [Q80TN5-2]
DR   UCSC; uc033fsq.1; mouse. [Q80TN5-1]
DR   CTD; 23390; -.
DR   MGI; MGI:2445110; Zdhhc17.
DR   eggNOG; KOG0509; Eukaryota.
DR   GeneTree; ENSGT00530000063074; -.
DR   HOGENOM; CLU_012510_3_1_1; -.
DR   InParanoid; Q80TN5; -.
DR   OMA; PWMAGIF; -.
DR   PhylomeDB; Q80TN5; -.
DR   TreeFam; TF317342; -.
DR   BioGRID-ORCS; 320150; 0 hits in 53 CRISPR screens.
DR   ChiTaRS; Zdhhc17; mouse.
DR   PRO; PR:Q80TN5; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   RNAct; Q80TN5; protein.
DR   Bgee; ENSMUSG00000035798; Expressed in retina and 248 other tissues.
DR   Genevisible; Q80TN5; MM.
DR   GO; GO:0016235; C:aggresome; ISO:MGI.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; ISS:UniProtKB.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0015095; F:magnesium ion transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0016409; F:palmitoyltransferase activity; IDA:MGI.
DR   GO; GO:0019705; F:protein-cysteine S-myristoyltransferase activity; IC:UniProtKB.
DR   GO; GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0140439; F:protein-cysteine S-stearoyltransferase activity; IC:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; IMP:UniProtKB.
DR   GO; GO:0042953; P:lipoprotein transport; ISO:MGI.
DR   GO; GO:0018230; P:peptidyl-L-cysteine S-palmitoylation; IDA:UniProtKB.
DR   GO; GO:0018345; P:protein palmitoylation; IDA:UniProtKB.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0051386; P:regulation of neurotrophin TRK receptor signaling pathway; IMP:UniProtKB.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR001594; Palmitoyltrfase_DHHC.
DR   InterPro; IPR030289; ZDHHC17.
DR   PANTHER; PTHR24161:SF18; PTHR24161:SF18; 1.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF01529; DHHC; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 5.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 5.
DR   PROSITE; PS50216; DHHC; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Alternative splicing; ANK repeat; Cell junction;
KW   Cell membrane; Cell projection; Cytoplasmic vesicle; Golgi apparatus;
KW   Lipoprotein; Membrane; Palmitate; Reference proteome; Repeat; Synapse;
KW   Transferase; Transmembrane; Transmembrane helix; Tumor suppressor.
FT   CHAIN           1..632
FT                   /note="Palmitoyltransferase ZDHHC17"
FT                   /id="PRO_0000212901"
FT   TOPO_DOM        1..304
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        305..325
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        326..346
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        347..357
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        358..378
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        379..381
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        382..402
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        403..480
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        481..501
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        502..529
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        530..550
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        551..632
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          51..86
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUH5"
FT   REPEAT          89..118
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          123..152
FT                   /note="ANK 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          156..185
FT                   /note="ANK 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          189..219
FT                   /note="ANK 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          224..253
FT                   /note="ANK 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          257..286
FT                   /note="ANK 7"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          437..487
FT                   /note="DHHC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00067"
FT   REGION          11..305
FT                   /note="Necessary and sufficient for interaction with DNAJC5
FT                   and SNAP25"
FT                   /evidence="ECO:0000269|PubMed:25253725"
FT   ACT_SITE        467
FT                   /note="S-palmitoyl cysteine intermediate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUH5"
FT   VAR_SEQ         423..429
FT                   /note="TIVELAE -> VVMYPAN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12693553"
FT                   /id="VSP_010026"
FT   VAR_SEQ         430..632
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12693553"
FT                   /id="VSP_010027"
FT   MUTAGEN         465
FT                   /note="H->Q: Loss of palmitoyltransferase activity toward
FT                   DNAJC5 and SNAP25."
FT                   /evidence="ECO:0000269|PubMed:25253725"
FT   MUTAGEN         467
FT                   /note="C->A: No effect on interaction with DNAJC5 and
FT                   SNAP25."
FT                   /evidence="ECO:0000269|PubMed:25253725"
FT   CONFLICT        288
FT                   /note="N -> K (in Ref. 1; BAC32912)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   632 AA;  72621 MW;  323EFD47790750DC CRC64;
     MQREEGFNTK MADGPDEYET ETGCVPLLHP EEIKPQSHYN HGYGEPLGRK THIDDYSTWD
     IVKATQYGIY ERCRELVEAG YDVRQPDKEN VTLLHWAAIN NRIDLVKYYI SKGAIVDQLG
     GDLNSTPLHW ATRQGHLSMV VQLMKYGADP SLIDGEGCSC IHLAAQFGHT SIVAYLIAKG
     QDVDMMDQNG MTPLMWAAYR THSVDPTRLL LTFNVSVNLG DKYHKNTALH WAVLAGNTTV
     ISLLLEAGGN VDAQNVKGES ALDLAKQRKN VWMINHLQEA RQAKGYDNPS FLRKLKADKE
     FRQKVMLGTP FLVIWLVGFI ADLDIDSWLI KGLMYGGVWA TVQFLSKSFF DHSMHSALPL
     GIYLATKFWM YVTWFFWFWN DLNFLFIHLP FLANSVALFY NFGKSWKSDP GIIKATEEQK
     KKTIVELAET GSLDLSIFCS TCLIRKPVRS KHCGVCNRCI AKFDHHCPWV GNCVGAGNHR
     YFMGYLFFLL FMICWMIYGC VSYWGLHCET TYTKDGFWTY ITQIATCSPW MFWMFLNSVF
     HFLWVAVLLM CQLYQITCLG ITTNERMNAR RYKHFKVTTT SIESPFNHGC VRNIIDFFEF
     RCCGLFRPVI VDWTRQYTIE YDQISGSGYQ LV
//
